Related Experiment Video
Updated: May 26, 2026
07:03
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Relationship between non-alcoholic fatty liver disease and pulmonary function
1Department of Family Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Internal Medicine Journal
|December 21, 2011
Summary
Non-alcoholic fatty liver disease (NAFLD) is linked to reduced pulmonary function. This study found that NAFLD patients had lower forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1).
Area of Science:
- Hepatology
- Pulmonology
- Cardiology
- Metabolic Syndrome
Background:
- Non-alcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular disease risk and insulin resistance.
- Pulmonary function is independently linked to cardiovascular disease and metabolic syndrome.
Purpose of the Study:
- To investigate the association between non-alcoholic fatty liver disease (NAFLD) and pulmonary function.
- To determine if NAFLD impacts key pulmonary function metrics like FVC and FEV1.
Main Methods:
- A cross-sectional study of 2119 Korean men aged 30-75.
- NAFLD diagnosed via abdominal sonography.
- Pulmonary function assessed by forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1), analyzed using logistic regression.
Main Results:
- Individuals with NAFLD exhibited significantly lower FVC and FEV1 compared to those without NAFLD.
- A dose-response relationship was observed, with pulmonary function declining progressively as the grade of hepatic steatosis increased.
- Multivariate analysis confirmed an independent inverse association between NAFLD and reduced FVC and FEV1 after adjusting for multiple confounding factors.
Conclusions:
- Non-alcoholic fatty liver disease (NAFLD) is independently associated with diminished pulmonary function.
- The severity of NAFLD correlates inversely with pulmonary function, suggesting a potential impact on respiratory health.
More Related Videos
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...